Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

« Breuer Defends The FCPA, As Is | Main | Does Graft Predict Debt Woes? »
Tuesday
Nov082011

AZ Indicted For Bribery In Serbia

U.K.-based pharma AstraZeneca said its office in Belgrade, Serbia was served with a criminal indictment 'relating to allegations that local employees . . . made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.' 

The disclosure appeared in AZ's lastest SEC filing. It said the indictment was issued in August 2011.

The company said it has 'filed a number of preliminary procedural objections, which ask the Serbian criminal court to dismiss the indictment.'

Overseas sales practices of the big pharmas have been in the FCPA spotlight.

AstraZeneca appeared on our Corporate Investigations List. In October 2006, it received from the SEC a letter requesting 'documents related to its business activities in Croatia, Italy, Russia, and Slovakia for the period 1 October 2003 to the present.'

The SEC’s investigative letter asked AZ for documents concerning payments to doctors or government officials, and related internal accounting controls.

'The [SEC] request also seeks policies, correspondence, audits and other documents,' AZ said in its 2009 annual report, 'concerning compliance with the Foreign Corrupt Practices Act, as well as any allegations or communications with prosecutors’ offices relating to corruption or bribery of doctors or government officials.'

Doctors at overseas government-owned or controlled hospitals are considered 'foreign officials' under the FCPA.

AstraZeneca had revenues last year of $33.5 billion. It does business, according to its website, in more than 100 countries, including China, Brazil, Mexico, and Russia. It has about 61,000 employees.

AstraZeneca PLC trades on the NYSE under the symbol AZN.

Its Form 6-K (Report of Foreign Issuer) filed November 7, 2011 can be viewed or downloaded here.

__________

AZ's complete disclosure about the Serbian indictment said:

In August 2011, AstraZeneca UK Limited’s Representative Office in Belgrade, Serbia was served with a criminal indictment relating to allegations that local employees of AstraZeneca made allegedly improper payments to physicians at the Institute of Oncology and Radiology of Serbia.  AstraZeneca has filed a   number of preliminary procedural objections, which ask the Serbian criminal court to dismiss the indictment against the Representative Office.

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
All HTML will be escaped. Hyperlinks will be created for URLs automatically.